We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agennix Announces Data From Talactoferrin Phase II Trial in Severe Sepsis

News   Jan 24, 2011

 
Agennix Announces Data From Talactoferrin Phase II Trial in Severe Sepsis
 
 
 

RELATED ARTICLES

Cellular Dumpster-diving Enables Degradation Landscape Exploration

News

A novel technology for profiling protein turnover and degradation offers new insight into diagnosis and understanding the molecular basis of autoimmunity, cancer, neurodegeneration and other disorders.

READ MORE

Aspirin Stops Clots After Knee Surgery

News

Putting patients on aspirin following a knee replacement is a safe, cost-effective alternative to anticoagulants, U-M researchers find.

READ MORE

Treating the Prostate with Radiotherapy Improves Survival

News

Treating the prostate with radiotherapy alongside standard treatment led to a 11 percent increase in survival for some men with advanced prostate cancer, shows trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE